Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Journal of Lipid Research
|
March 1, 1995
Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein
M C de Beer, T Yuan, M S Kindy, et al.
The Journal of Biological Chemistry
|
April 1, 2000
Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I
U J Tietge, C Maugeais, W Cain, et al.
The American Journal of Pathology
|
November 1, 1993
Characterization of the inbred CE/J mouse strain as amyloid resistant
J D Sipe, I Carreras, W A Gonnerman, et al.
Journal of Lipid Research
|
February 22, 2001
Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI
M C de Beer, D M Durbin, L Cai, et al.
The Biochemical Journal
|
October 1, 1988
Phosphorylation of human serum amyloid A protein by protein kinase C
A E Nel, M C De Beer, E G Shephard, et al.
British Journal of Obstetrics and Gynaecology
|
August 1, 1990
C-reactive protein and serum amyloid A protein in pregnancy and labour
W J de Villiers, J P Louw, A F Strachan, et al.
Journal of Lipid Research
|
October 1, 1996
Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells
J S Liang, B M Schreiber, M Salmona, et al.
Journal of Immunological Methods
|
November 7, 1985
Standardisation of the quantitation of serum amyloid A protein (SAA) in human serum
N L Godenir, M S Jeenah, G A Coetzee, et al.
Journal of Lipid Research
|
April 7, 1999
Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
H Hosoai, N R Webb, J M Glick, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1984
Serum C-reactive protein levels in the management of infection in acute leukaemia
I D Starke, F C de Beer, J P Donnelly, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Journal of Lipid Research
|
March 1, 1995
Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein
M C de Beer, T Yuan, M S Kindy, et al.
The Journal of Biological Chemistry
|
April 1, 2000
Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I
U J Tietge, C Maugeais, W Cain, et al.
The American Journal of Pathology
|
November 1, 1993
Characterization of the inbred CE/J mouse strain as amyloid resistant
J D Sipe, I Carreras, W A Gonnerman, et al.
Journal of Lipid Research
|
February 22, 2001
Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI
M C de Beer, D M Durbin, L Cai, et al.
The Biochemical Journal
|
October 1, 1988
Phosphorylation of human serum amyloid A protein by protein kinase C
A E Nel, M C De Beer, E G Shephard, et al.
British Journal of Obstetrics and Gynaecology
|
August 1, 1990
C-reactive protein and serum amyloid A protein in pregnancy and labour
W J de Villiers, J P Louw, A F Strachan, et al.
Journal of Lipid Research
|
October 1, 1996
Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells
J S Liang, B M Schreiber, M Salmona, et al.
Journal of Immunological Methods
|
November 7, 1985
Standardisation of the quantitation of serum amyloid A protein (SAA) in human serum
N L Godenir, M S Jeenah, G A Coetzee, et al.
Journal of Lipid Research
|
April 7, 1999
Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
H Hosoai, N R Webb, J M Glick, et al.
European Journal of Cancer & Clinical Oncology
|
March 1, 1984
Serum C-reactive protein levels in the management of infection in acute leukaemia
I D Starke, F C de Beer, J P Donnelly, et al.
Page
of 10